Hamada, A.
25174  results:
Search for persons X
?
1

OA15.06 Differences in Pathologic Assessment by MPR Calcula..:

Kashima, J. ; Inamura, K. ; Hamada, A....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S80-S81 , 2023
 
?
2

P1.08-05 On-Target Acquired Resistance to Mobocertinib and ..:

Hamada, A. ; Suda, K. ; Fukuda, S....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S198-S199 , 2023
 
?
3

P1.26-06 Harmonized Maximum Standardized Uptake Value as an..:

Adachi, M. ; Yoshida, Y. ; Yotsukura, M....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S280 , 2023
 
?
4

P1.25-01 Real-World Data of Completely Resected Lung Adenoc..:

Katsumata, S. ; Hamada, A. ; Haratake, N....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S267-S268 , 2023
 
?
6

EP11.03-08 Multicenter Pharmacokinetic Study of Pembrolizum..:

Horinouchi, H. ; Ohe, Y. ; Yamanaka, Y....
Journal of Thoracic Oncology.  18 (2023)  11 - p. S622 , 2023
 
?
7

EP08.02-085 In vitro Activity and Potential Resistance Muta..:

Suda, K. ; Fujino, T. ; Hamada, A....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S442 , 2022
 
?
8

124P Phase II study of neoadjuvant concurrent chemo-immuno-..:

Miyoshi, T. ; Hamada, A. ; Soh, J....
Immuno-Oncology and Technology.  16 (2022)  - p. 100236 , 2022
 
?
 
?
10

EP08.02-146 Proposal of Foretinib as Second-Line TKI after ..:

Fujino, T. ; Suda, K. ; Koga, T....
Journal of Thoracic Oncology.  17 (2022)  9 - p. S472-S473 , 2022
 
?
 
?
 
?
14

Eldecalcitol (ED-71)-induced exosomal miR-6887-5p suppresse..:

Higaki, M. ; Shintani, T. ; Hamada, A...
In Vitro Cellular & Developmental Biology. Animal.  56 (2020)  3 - p. 222-233 , 2020
 
?
15

Eldecalcitol (ED-71)-induced exosomal miR-6887-5p suppresse..:

Higaki, M. ; Shintani, T. ; Hamada, A...
In Vitro Cellular & Developmental Biology - Animal.  56 (2020)  3 - p. 222-233 , 2020
 
1-15